000286662 001__ 286662
000286662 005__ 20241127133736.0
000286662 0247_ $$2doi$$a10.1007/s00520-023-08269-2
000286662 0247_ $$2pmid$$apmid:38170301
000286662 0247_ $$2ISSN$$a0941-4355
000286662 0247_ $$2ISSN$$a1433-7339
000286662 0247_ $$2altmetric$$aaltmetric:158191215
000286662 037__ $$aDKFZ-2024-00026
000286662 041__ $$aEnglish
000286662 082__ $$a610
000286662 1001_ $$0P:(DE-He78)f42e2297e771e17df08f2cc1171df9e4$$aGoldschmidt, Siri$$b0$$eFirst author$$udkfz
000286662 245__ $$aPatterns and influencing factors of exercise attendance of breast cancer patients during neoadjuvant chemotherapy.
000286662 260__ $$aNew York,NY$$bSpringer$$c2024
000286662 3367_ $$2DRIVER$$aarticle
000286662 3367_ $$2DataCite$$aOutput Types/Journal article
000286662 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1704372577_7492
000286662 3367_ $$2BibTeX$$aARTICLE
000286662 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000286662 3367_ $$00$$2EndNote$$aJournal Article
000286662 500__ $$a#EA:C110#LA:C110#
000286662 520__ $$aPerforming 2-3 exercise sessions/week may relieve therapy-related side effects of breast cancer patients (BRCA) and improve their quality of life. However, attendance to the exercise sessions is often impaired. Thus, we investigated patterns and possible influencing factors of attendance to an aerobic (AT) or resistance training (RT) intervention in BRCA during neoadjuvant chemotherapy.BRCA (N = 122) were randomly allocated to supervised AT or RT twice weekly during neoadjuvant chemotherapy (18 ± 4 weeks). Attendance was calculated individually and group-wise per training week as the percentage of the performed sessions out of the prescribed sessions. Possible influencing factors were investigated using multiple regression analyses.Mean individual attendance was 44.1% ± 29.3% with no significant differences between the groups. Group-wise attendance was highest in the first 6 weeks of training with ≥ 60% for AT and ≥ 50% for RT, but decreased over the course of the intervention accompanying chemotherapy. Significantly higher attendance was associated with not having vs. having nausea (ß = - 14.57; p = 0.007) and not having vs. having pain (ß = - 12.07; p = 0.12), whereas fatigue did not show any association (ß = - 0.006; p = 0.96). Having been randomized into a preferred intervention group (48.8%) showed no association with attendance. Yet, patients' rating of the exercise intervention as 'good'/ 'very good' (58.7%) was significantly associated with higher attendance (p = 0.01).For both exercise interventions, group-wise attendance/training week decreased during chemotherapy despite good intervention ratings. While some patients never started, others trained almost constantly twice weekly. The study revealed that patients who are nauseous or experience pain may need more support to attend more exercise sessions. Trial Registration Clinicaltrials.gov: NCT02999074 from May 6, 2016.
000286662 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000286662 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000286662 650_7 $$2Other$$aAttendance
000286662 650_7 $$2Other$$aBreast neoplasms
000286662 650_7 $$2Other$$aExercise intervention
000286662 650_7 $$2Other$$aNeoadjuvant chemotherapy
000286662 7001_ $$0P:(DE-He78)2def8f8594c8f797f5ed4398258c6cac$$aSchmidt, Martina$$b1$$udkfz
000286662 7001_ $$aRosenberger, Friederike$$b2
000286662 7001_ $$aWiskemann, Joachim$$b3
000286662 7001_ $$0P:(DE-He78)a0c2037d9054be26907a05ae520d5756$$aSteindorf, Karen$$b4$$eLast author$$udkfz
000286662 773__ $$0PERI:(DE-600)1463166-0$$a10.1007/s00520-023-08269-2$$gVol. 32, no. 1, p. 79$$n1$$p79$$tSupportive care in cancer$$v32$$x0941-4355$$y2024
000286662 8564_ $$uhttps://inrepo02.dkfz.de/record/286662/files/s00520-023-08269-2.pdf
000286662 8564_ $$uhttps://inrepo02.dkfz.de/record/286662/files/s00520-023-08269-2.pdf?subformat=pdfa$$xpdfa
000286662 909CO $$ooai:inrepo02.dkfz.de:286662$$pVDB
000286662 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f42e2297e771e17df08f2cc1171df9e4$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000286662 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)2def8f8594c8f797f5ed4398258c6cac$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000286662 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a0c2037d9054be26907a05ae520d5756$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000286662 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000286662 9141_ $$y2024
000286662 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2023-10-21$$wger
000286662 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2023-10-21$$wger
000286662 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-21
000286662 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-21
000286662 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-21
000286662 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-21
000286662 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-21
000286662 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-21
000286662 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-10-21
000286662 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bSUPPORT CARE CANCER : 2022$$d2023-10-21
000286662 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-10-21
000286662 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-10-21
000286662 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2023-10-21
000286662 9202_ $$0I:(DE-He78)C110-20160331$$kC110$$lBewegung, Präventionsforschung und Krebs$$x0
000286662 9201_ $$0I:(DE-He78)C110-20160331$$kC110$$lBewegung, Präventionsforschung und Krebs$$x0
000286662 9200_ $$0I:(DE-He78)C110-20160331$$kC110$$lBewegung, Präventionsforschung und Krebs$$x0
000286662 980__ $$ajournal
000286662 980__ $$aVDB
000286662 980__ $$aI:(DE-He78)C110-20160331
000286662 980__ $$aUNRESTRICTED